Edwards Lifesciences Corporation provided earnings guidance for the fourth quarter of 2022. For the quarter, the company expects year-over-year and sequential sales growth in constant currency. The company expects reported sales and adjusted EPS to be similar to the third quarter.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
87.46 USD | +2.78% | +2.69% | +14.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.56% | 51.28B | |
+8.75% | 219B | |
+8.12% | 185B | |
+14.41% | 135B | |
+27.75% | 107B | |
+4.48% | 51.01B | |
+3.99% | 41.85B | |
+6.35% | 37.02B | |
+25.50% | 31.27B | |
+16.53% | 23.66B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation Provides Earnings Guidance for the Fourth Quarter of 2022